Institute

Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute, talks tumours and how she aims to target them.

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

This International Women’s Day, meet the women combining research and clinical expertise with business acumen and personal experience to help…

For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research

Disrupted cell signalling, hijacked stem cells and the power of ‘mini-guts’ – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

In 2019, we launched our flagship early detection initiative, the International Alliance for Cancer Early Detection (ACED), to address the…

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers…

The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow.